Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. - Wikidata - awgldk - TriplyDB

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline.

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline.

http://www.wikidata.org/entity/Q34095444

about

Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25 Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta Early prenatal stress epigenetically programs dysmasculinization in second-generation offspring via the paternal lineage Molecular pathogenesis of pulmonary arterial hypertension Microarray analysis in pulmonary hypertension Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs Regulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signalling MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension MicroRNAs in respiratory disease. A clinician's overview OxymiRs in cutaneous development, wound repair and regeneration Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension Human mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cells Regulation and function of miR-214 in pulmonary arterial hypertension.Assessment of microRNA and gene dysregulation in pulmonary hypertension by endoarterial biopsy.MicroRNAs in right ventricular (dys)function (2013 Grover Conference series).MicroRNA expression profile of pulmonary artery smooth muscle cells and the effect of let-7d in chronic thromboembolic pulmonary hypertension Transient but not genetic loss of miR-451 is protective in the development of pulmonary arterial hypertension Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p Differentially expressed plasma microRNAs and the potential regulatory function of Let-7b in chronic thromboembolic pulmonary hypertension.Elevated microRNA-135a is associated with pulmonary arterial hypertension in experimental mouse model.MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer.MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts HypoxamiR regulation and function in ischemic cardiovascular diseases.Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation.Therapeutic implications of microRNAs in pulmonary arterial hypertension.Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.Enhancer of zeste homolog 2 induces pulmonary artery smooth muscle cell proliferation.An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation Hypoxia represses microRNA biogenesis proteins in breast cancer cells.A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity.MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy Role for miR-204 in human pulmonary arterial hypertension Stretch-sensitive down-regulation of the miR-144/451 cluster in vascular smooth muscle and its role in AMP-activated protein kinase signaling Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries.

P2860

Q21134128-D752DFBC-3E5F-4B12-B122-3C94154A99CB Q24600228-531F4D1D-F003-4B42-B796-1E919CBCD856 Q24607916-A1125726-F364-4FE9-9EA3-BFF8D02A0089 Q24634317-C36E3B65-D80A-4643-9BBC-BCFFEFA22388 Q26748607-A0A00C1B-BCF2-4802-A712-0ADA0896846F Q26766294-E61AC847-A859-4772-948B-A672EA364E54 Q26767134-2EB51B71-1F13-4DE8-8AD0-0B531C38DE6F Q26796557-4BB22BEC-214D-4CB5-A749-67A7CA714036 Q26823456-99CC3A05-002E-4CE4-AA2C-8E7B3C421AD8 Q27024906-9A281B87-D25C-4F19-8E6D-634B0F089235 Q27026074-5D35993E-3474-4A22-A1D8-833D8254620F Q28067063-5ABA24BA-7204-43B1-8608-20E5F6C071AC Q28117980-49A6C91F-D3EF-4855-AE58-BFE08C14EBDF Q28118456-30223521-9277-413F-9A2A-884F05867D1D Q28535304-2AD304B3-B792-4A30-A510-1915D1164E0F Q32884388-99353C25-BEDE-471D-A234-044D972504CE Q33788516-9072642D-FFC5-4B37-8D98-8CDAA08BE3AA Q33806013-E11103F1-8517-4519-9103-1FC411B05E7E Q33806115-C871E914-8047-4E95-AD91-EE6D6E157FDE Q33806212-710EA8EB-6A0F-4123-A570-A756A6C4C7B4 Q33818129-9898F6D3-381A-4DA9-AC4B-79E0ECFBB83B Q33825547-C416F73E-7678-47A4-9F90-17056AEC94A9 Q33829248-53B39034-9FEF-4794-93A6-8DF5A3D66AED Q33886348-EBDDCAF8-D85A-4042-9CBF-39A2D3659B5B Q33982509-45598EFF-F311-4D75-9845-4B08EC3437BC Q34082010-B77AD5D9-92C5-485C-9CFF-6439BA0FF18D Q34160776-3C579333-7058-4B5E-82D8-B54F1AA1E5A1 Q34179986-C9204BCF-ACB8-4089-9705-A1E582AA4110 Q34270071-9D738A8E-60EA-48F7-9A15-89DBBCEBDE0C Q34291184-29C673DB-C26A-45EF-AFEA-566F190F9814 Q34319305-375CAFA4-15DB-40E3-A354-B77DEC6EFF82 Q34426103-D9A86B4F-FE22-4F7E-B9B6-5A8AB931B8F0 Q34447498-5D654B01-CBBE-4F18-8955-DD7C31F2FCCD Q34469837-88AE2D00-6057-4A52-8E8E-DC955801BABA Q34477363-EA15C866-59C4-4B95-A5C5-F10D07392224 Q34551993-519A8047-8351-4C03-BCE6-695DC3A63A40 Q34681312-341D2C9D-4872-4434-A54D-AEED066D5A4B Q34738318-D39FD483-2451-4C2D-ADA6-84A70A7BFAC3 Q34945488-EED1500C-1E82-440D-BDE2-138C0DE2816A Q34990770-C7C822CD-3653-40F8-8A58-6C72F87D3833

P2860

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline.

http://www.wikidata.org/entity/Q34095444

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@ast

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@en

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@nl

type

label

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@ast

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@en

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@nl

prefLabel

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@ast

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@en

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@nl

P1433

Q34095444-51376A3F-977E-40C7-90FC-9C9334D84F4B

P1476

Q34095444-3E296C17-FD8E-407D-BC10-EBAD40F86437

P2093

Q34095444-3B094F27-BCF4-436F-B9C3-53DA9AFBFEAD

Q34095444-60259586-0D3C-48BB-8C71-D6830D976023

Q34095444-6FBE0EE8-2F0E-496F-B79B-AC0D061B0F3B

Q34095444-7203D66C-5A2C-48CB-8687-EEA8C86C90ED

Q34095444-7AE89BC8-A19A-49D7-8CD6-8A2CE370A85E

Q34095444-9086DAC2-1B76-4CB5-9963-E2DE20186942

Q34095444-AA8DE92B-1279-4F5C-AF3B-B3DC557931F2

Q34095444-B1FC4E2D-56FD-4A68-9B2F-F54AD34E8A07

Q34095444-D171ACAE-7FC6-4C7F-BDC5-6929F69ABCBF

Q34095444-D2512CB7-78EF-4815-9EDE-F12C7DA033A7

P304

Q34095444-E393477F-9136-42D8-8B97-B4BE634F75C2

P31

Q34095444-BBFD9F92-BCFA-466E-A161-920969028C8E

P356

Q34095444-30935A7C-17AC-4C6E-A587-1DB3B6446EC2

P407

Q34095444-0BEFA35B-6BE8-4766-B5A3-564EEE0527EF

P433

Q34095444-7809D987-903A-4A05-8640-6AC8D472C0DD

P478

Q34095444-371CD6A5-5DF6-4639-BA41-3908EEE140BC

P50

Q34095444-1EC9B9EE-45BA-4F1F-8ADA-5BCF9553FEFC

Q34095444-49B77C0F-FE4B-48B0-9E85-199058AF1122

Q34095444-E99FE79C-6D45-4708-A1C8-A77E60A13FF5

P577

Q34095444-44A6CE43-75C6-42D3-A58F-442C7718B883

P698

Q34095444-1250AF3E-E96D-4A3B-93F2-56E7BC89325B

P921

Q34095444-C81DA86F-115D-4289-A140-7B500C0F9822

Q34095444-E6291BF6-962C-4468-BBFE-51BC9CC13124

P356

ATVBAHA.109.202028

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Dynamic changes in lung microR ...... nic hypoxia and monocrotaline.

@en

P2093

Andrew H Baker

http://www.w3.org/2001/XMLSchema#string

Jenny A Greig

http://www.w3.org/2001/XMLSchema#string

John McClure

http://www.w3.org/2001/XMLSchema#string

Keith E Robertson

http://www.w3.org/2001/XMLSchema#string

Laura Denby

http://www.w3.org/2001/XMLSchema#string

Lu Long

http://www.w3.org/2001/XMLSchema#string

Margaret R MacLean

http://www.w3.org/2001/XMLSchema#string

Mark Southgate

http://www.w3.org/2001/XMLSchema#string

Paola Caruso

http://www.w3.org/2001/XMLSchema#string

Rachel Masson

http://www.w3.org/2001/XMLSchema#string

P304

716-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.109.202028

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas W Morrell

P577

2010-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20110569

http://www.w3.org/2001/XMLSchema#string

P921